GlassScriptPhysician profile
Sharon M Dyer
NPI 1063866887
$3,563.11
in general payments reported to CMS, 2019-2025
16 companies · $805 in 2025
The $805 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.67 · 2020: $89.63 · 2021: $709 · 2022: $1,070 · 2023: $339 · 2024: $471 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,614.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,354.09 | 2022-2025 | Infuse, Ultra Multifocal Toric, Ic-8 Apthera Iol |
| Alcon Vision LLC | $507.86 | 2025 | Total30, Precision 1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $451.70 | 2020-2021 | |
| Coopervision INC. | $283.73 | 2022-2024 | Clariti Contact Lens |
| Sight Sciences, INC. | $169.29 | 2021 | |
| Amgen INC. | $144.55 | 2025 | |
| Dompe US, INC. | $131.71 | 2024 | Oxervate |
| Aerie Pharmaceuticals, INC. | $106.80 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $81.75 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $76.09 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $71.94 | 2019-2025 | |
| Glaukos Corporation | $64.81 | 2022 | |
| Rxsight INC | $36.37 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Tarsus Pharmaceuticals, INC. | $31.39 | 2025 | Xdemvy |
| Abbvie INC. | $27.23 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis, INC | $23.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.